Cell Saver for On-pump Coronary Operations Reduces Systemic Inflammatory Markers: A Randomized Trial

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1511-1517

  Damgaard, Sune ^a   Nielsen, Claus H ^b   Andersen, Lars W ^a   Bendtzen, Klaus ^b   Tvede, Michael ^a   Steinbrüchel, Daniel A ^a  

^a Rigshospitalet   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFUROXIME; GENTAMICIN; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MORPHINE; PARACETAMOL; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; AUTACOID; CALCITONIN; INTERLEUKIN DERIVATIVE; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CELL SAVER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DISEASE MARKER; ERYTHROCYTE TRANSFUSION; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MEDICAL INSTRUMENTATION; ON PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; PERICARDIUM; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUND DEHISCENCE; BLOOD; BLOOD AUTOTRANSFUSION; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATION; PROBABILITY; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; BLOOD TRANSFUSION, AUTOLOGOUS; CALCITONIN; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953032036     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.02.003     Document Type: Article

References (16)

1. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
2. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
3. Marano C.W., Garulacan L.A., Laughlin K.V., et al. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass. Ann Thorac Surg 70 (2000) 1313-1318
4. Andersen L.W., Baek L., Degn H., Lehd J., Krasnik M., and Rasmussen J.P. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93 (1987) 115-119
5. Kerbaul F., Guidon C., Lejeune P.J., Mollo M., Mesana T., and Gouin F. Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 16 (2002) 47-53
6. Lin E., Calvano S.E., and Lowry S.F. Inflammatory cytokines and cell response in surgery. Surgery 127 (2000) 117-126
7. Serrick C.J., Scholz M., Melo A., Singh O., and Noel D. Quality of red blood cells using autotransfusion devices: a comparative analysis. J Extra Corpor Technol 35 (2003) 28-34
8. Carless P.A., Henry D.A., Moxey A.J., O'connell D.L., Brown T., and Fergusson D.A. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2006) CD001888
9. Warren O., Alexiou C., Massey R., et al. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg 31 (2007) 665-676
10. Hsu L.C. Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 16 (2001) 417-428
11. Amand T., Pincemail J., Blaffart F., Larbuisson R., Limet R., and Defraigne J.O. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 17 (2002) 117-123
12. Svenmarker S., and Engstrom K.G. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving. Scand Cardiovasc J 37 (2003) 158-164
13. Aldea G.S., Soltow L.O., Chandler W.L., et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123 (2002) 742-755
14. Westerberg M., Bengtsson A., and Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 78 (2004) 54-59
15. Skrabal C.A., Khosravi A., Choi Y.H., et al. Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass. Scand Cardiovasc J 40 (2006) 219-223
16. Allen S.J., McBride W.T., McMurray T.J., et al. Cell salvage alters the systemic inflammatory response after off-pump coronary artery bypass grafting surgery. Ann Thorac Surg 83 (2007) 578-585